The global kidney stones diagnosis and treatment market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period. The market growth is attributed to various factors including the increasing incidences of urolithiasis and an increase in the efficacy of the products that provide convenience for the patients. The evolution of new technologies is creating demand for minimally invasive procedures with faster recovery and minimum discomfort, which further drives the growth of the market. Increasing awareness across the globe, rising healthcare infrastructure, and intake of antacid, protein & oxalate-containing food create future opportunities for the expansion and growth of the market.

Impact of COVID-19 Pandemic on Global Kidney Stones Diagnosis and Treatment Market

The kidney stones diagnosis and treatment market was impacted by COVID-19 due to lower hospital and diagnostic center visits due to the high penetration of COVID-19 across the globe. However, in the second quarter, the ease of COVID-19 measures has benefited the overall industry growth.

Segmental Outlook 

The global kidney stones diagnosis and treatment market is segmented based on the types, diagnosis, and treatment. Based on the types, the market is segmented into calcium stone, uric acid stone, struvite stone, and cystine stone. Based on the diagnosis, the market is sub-segmented into imaging, blood testing, urine testing, and others. Based on the treatment, the market is sub-segmented into extracorporeal shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy. The above-mentioned segments can be customized as per the requirements. Among these, the ureteroscopy segment is expected to be the fastest-growing segment in the global kidney stones diagnosis and treatment market during the forecast period as ureteroscopy is a commonly used method for the treatment of kidney stones. This treatment is recommended specifically when kidney stones are of large size stones.

Global Kidney Stones Diagnosis and Treatment Market Share by Type, 2021 (%)

The Calcium-Stone Segment Holds the Prominent Share in the Global Kidney Stones Diagnosis and Treatment Market

The calcium-stone segment is expected to hold a prominent share in the global kidney stones diagnosis and treatment market as it is commonly occurring kidney stones in the body that form due to the high level of oxalate in the urine and lesser intake of water. Several key players are developing their devices to stay competitive in the market. For instance, in January 2022, Applaud Medical received FDA breakthrough device designation for its Acoustic Enhancer technology. The company designed its Acoustic Enhancer technology for use in conjunction with ureteroscopy with laser lithotripsy (URS-LL) for the fragmentation of calcium-based urinary stones (at least 6mm and not more than 20mm in diameter) that are blocking or deemed to present a significant risk of future obstruction by a urologist or other qualified physician.

Regional Outlooks

The global kidney stones diagnosis and treatment market are further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America).  The Asia-Pacific is expected to be the fastest-growing region during the forecast period due to the rising prevalence of diseases, increasing awareness among people about the disease, and developing healthcare infrastructure. 

Global Kidney Stones Diagnosis and Treatment Market Growth, by Region 2022-2028

The North American Region is anticipated to hold the Prominent Share in the Global Kidney Stones Diagnosis and Treatment Market

North America region is estimated to hold a prominent share in the global kidney stones diagnosis and treatment market due to the increasing awareness among the patient population about new treatment options for stone diseases and the availability of advanced medical devices in the region, which are assisting the expansion of the regional market. Furthermore, Factors such as higher acceptance of technologically advanced products in the region, increasing healthcare expenditures, and favorable reimbursement policies are responsible for the share of the market.

Market Players Outlook

The major companies serving the global kidney stones diagnosis and treatment market include Allengers Medical Systems Ltd., C.R. Bard Inc., Boston Scientific Corp., Cook Medical Inc., Karl Storz SE& Co. KG, Convergent Laser Technologies, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, UF Health launches an NIH-sponsored trial to ‘POuND OUT’ painful kidney stones drug trials aimed at preventing uric acid kidney stones. The study will use two drugs, phentermine, and topiramate, to treat obesity, insulin resistance, and overly acidic urine, with a primary goal of preventing the growth of uric acid stones and the formation of new ones. The trial will explore whether the drugs can be used to support lifestyle changes that reduce the amount of acid secreted by the kidney.

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global kidney stones diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.